Inogen Inc reports results for the quarter ended June 30 - Earnings Summary

• Inogen Inc INGN.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -24 cents. The mean expectation of three analysts for the quarter was for a loss of 27 cents per share. Wall Street expected results to range from -36 cents to -22 cents per share.

• Revenue rose 4% to $92.28 million from a year ago; analysts expected $90.60 million.

• Inogen Inc's reported EPS for the quarter was a loss of 15 cents​.

• The company reported a quarterly loss of $4.15 million.

• Inogen Inc shares had fallen by 10.4% this quarter and lost 31.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 7.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Inogen Inc is $13.00, about 54.8% above its last closing price of $5.87

This summary was machine generated from LSEG data August 8 at 04:25 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)